Jane Street
IART icon

Jane Street’s Integra LifeSciences IART Stock Holding History

Jane Street’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25,800
Closed -$1.39M – 10013
2022
Q2 		$1.39M Buy
+25,800
New +$1.55M ﹤0.01% 4857
2022
Q1 		– Sell
-14,300
Closed -$958K – 10607
2021
Q4 		$958K Buy
+14,300
New +$967K ﹤0.01% 5986

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Paradigm Capital Management Inc
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.06% 1-Year Est. Return

Jane Street's IART Position: Q2 2026 in Review

Jane Street sold out of Integra LifeSciences (IART) in Q2 2026, closing a stake of 163,124 shares — an estimated $1.54M sold.

Jane Street first reported a position in IART in Q2 2014 and held it in 28 quarters. The position peaked at $11.3M in Q2 2024. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Jane Street reported no remaining Integra LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 163,124 Integra LifeSciences shares in Q2 2026, an estimated $1.54M.
  • Jane Street first reported a position in Integra LifeSciences in Q2 2014 and held it in 28 quarters.
  • Jane Street's Integra LifeSciences position peaked at $11.3M in Q2 2024.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.